CAR (Chimeric Antigen Receptor) T-Cell Therapy

Related topics:
CAR-T Therapy

This program features topics relevant to the multidisciplinary team approach to caring for patients receiving CAR T-cell therapies and their relatives.

CAR (Chimeric Antigen Receptor) T-Cell Therapy

Remerciements et droits d'auteur

The CAR (Chimeric Antigen Receptor) T-cell therapies: a resource for healthcare professionals learning program was made possible by an educational grant from Celgene / Bristol Myers Squibb Company, Janssen-Cilag AG, Novartis and Kite Gilead.

HNHCP logo
Retour en haut de page
Le contenu de cette page vous a-t-il été utile ? Envoyez-nous vos commentaires